These insights support the potential of functional foods or nutraceuticals targeting MICT1 activity, as well as combined diet–drug strategies, to prevent obesity and metabolic diseases through enhanced thermogenesis. Here, CLMB is linked to obesity due to melanocortin 4 receptor deficiency.